-globin mRNA in mammalian cells by antisense oligonucleotides
has been cited by the following articles in journals that are participating in CrossRef's forward linking service: |
||
| Therapeutic applications of aptamers Gurjot Kaur and Ipsita Roy Expert Opinion on Investigational Drugs (2008) 17: 43 Link to Article |
||
| Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice Natee Jearawiriyapaisarn, Hong M Moulton, Brian Buckley, Jennifer Roberts, Peter Sazani, Suthat Fucharoen, Patrick L Iversen, and Ryszard Kole Molecular Therapy (2008) Link to Article |
||
| Molecular therapies in ?-thalassaemia Lynn Quek and Swee Lay Thein British Journal of Haematology (2007) 136: 353 Link to Article |
||
| Comparative Analysis of Antisense Oligonucleotide Sequences for Targeted Skipping of Exon 51 During Dystrophin Pre-mRNA Splicing
in Human Muscle V. Arechavala-Gomeza, I.R. Graham, L.J. Popplewell, A.M. Adams, A. Aartsma-Rus, M. Kinali, J.E. Morgan, J.C. van Deutekom, S.D. Wilton, and G. Dickson Human Gene Therapy (2007) 18: 798 Link to Article |
||
| U7 snRNA-mediated correction of aberrant splicing caused by activation of cryptic splice sites Hideki Uchikawa, Katsunori Fujii, Yoichi Kohno, Noriyuki Katsumata, Kazuaki Nagao, Masao Yamada, and Toshiyuki Miyashita Journal of Human Genetics (2007) 52: 891 Link to Article |
||
| Dendritic α,ε-Poly(L-lysine)s as Delivery Agents for Antisense Oligonucleotides Khee Dong Eom, Sun Mi Park, Huu Dung Tran, Myong Soo Kim, Ri Na Yu, and Hoon Yoo Pharmaceutical Research (2007) 24: 1581 Link to Article |
||
| Antisense applications for biological control Wei-Hua Pan and Gary A. Clawson Journal of Cellular Biochemistry (2006) 98: 14 Link to Article |
||
| Analysis of Prostate-Specific Membrane Antigen Splice Variants in LNCap Cells Tiffany Williams and Ryszard Kole Oligonucleotides (2006) 16: 186 Link to Article |
||
| As Antisense RNA Gets Intronic Eduardo M. Reis, Rodrigo Louro, Helder I. Nakaya, and Sergio Verjovski-Almeida Omics A Journal of Integrative Biology (2005) 9: 2 Link to Article |
||
| Use of Antisense Oligonucleotides in Functional Genomics and Target Validation Lingamanaidu V. Ravichandran, Nicholas M. Dean, and Eric G. Marcusson Oligonucleotides (2004) 14: 49 Link to Article |
||
| Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense A AARTSMARUS, A JANSON, W KAMAN, M BREMMERBOUT, G VANOMMEN, J DENDUNNEN, and J VANDEUTEKOM The American Journal of Human Genetics (2004) 74: 83 Link to Article |
||
| Towards a therapeutic inhibition of dystrophin exon 23 splicing inmdx mouse muscle induced by antisense oligoribonucleotides
(splicomers): target sequence optimisation using oligonucleotide arrays Ian R. Graham, Vanessa J. Hill, Muthiah Manoharan, Gopal B. Inamati, and George Dickson The Journal of Gene Medicine (2004) 6: 1149 Link to Article |
||
| Antisense oligonucleotide therapy for urologic tumors Ingo Kausch and Andreas Böhle Current Urology Reports (2003) 4: 60 Link to Article |
||
| Antisense technologies. Improvement through novel chemical modifications Jens Kurreck European Journal of Biochemistry (2003) 270: 1628 Link to Article |
||
| Optimization of Functional Efficacy of Phosphorothioate-Modified Oligonucleotides in a Human CD8+ T-Cell Ex Vivo Expansion
Model N. A. Al-Shanti, C. G. Steward, and R. J. Garland Scandinavian Journal of Immunology (2003) 58: 462 Link to Article |
||
| Efficiency of Antisense Oligonucleotide Drug Discovery C. Frank Bennett Antisense and Nucleic Acid Drug Development (2002) 12: 215 Link to Article |
||
| Improved antisense oligonucleotide induced exon skipping in themdx mouse model of muscular dystrophy Christopher J. Mann, Kaite Honeyman, Graham McClorey, Sue Fletcher, and Stephen D. Wilton The Journal of Gene Medicine (2002) 4: 644 Link to Article |
||
| Antisense Oligonucleotide Therapy in Urology I. KAUSCH and A. B??HLE The Journal of Urology (2002) : 239 Link to Article |
||
| Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases Scott P Henry and Ronald P Danis Expert Opinion on Pharmacotherapy (2001) 2: 277 Link to Article |
||
| Promiscuity of Pre-mRNA Spliceosome-Mediated Trans Splicing: A Problem for Gene Therapy? Toyone Kikumori, Gilbert J. Cote, and Robert F. Gagel Human Gene Therapy (2001) 12: 1429 Link to Article |
||
| Reversal of aberrant splicing of beta-thalassaemia allele (IVS-2-654 CT) by antisense RNA expression vector in cultured human
erythroid cells Lan Gong, Xiao-Feng Gu, Yun-Di Chen, Zhao-Rui Ren, Shu-Zhen Huang, and Yi-Tao Zeng British Journal of Haematology (2000) 111: 351 Link to Article |
||
| Antisense oligonucleotide therapeutics C Frank Bennett Expert Opinion on Investigational Drugs (1999) 8: 237 Link to Article |
||
| A System for Shuttling 200-kb BAC/PAC Clones into Human Cells: Stable Extrachromosomal Persistence and Long-Term Ectopic Gene
Activation Eva Maria Westphal, Halina Sierakowska, Elisabeth Livanos, Ryszard Kole, and Jean-Michel Vos Human Gene Therapy (1998) 9: 1863 Link to Article |
||
| Alternative dystrophin gene transcripts in golden retriever muscular dystrophy Scott J. Schatzberg, Louise V.B. Anderson, Stephen D. Wilton, Joe N. Kornegay, Christopher J. Mann, Gregory G. Solomon, and Nicholas J.H. Sharp Muscle & Nerve (1998) 21: 991 Link to Article |
||
| Therapeutic repair of mutated nucleic acid sequences Tod M. Woolf Nature Biotechnology (1998) 16: 341 Link to Article |
||